Lexeo team
LEXEO’s management team consists of pioneers and driven leaders with decades of development experience in gene therapy and rare diseases.
Management Team

CHIEF EXECUTIVE OFFICER
R. Nolan Townsend

Chief Scientific Officer
Eric Adler, MD

Chief Technical Officer
Paul McCormac, PhD

Chief Financial Officer
Micah Zajic

Senior Vice President, General Counsel & Head of People
Jenny Robertson

Senior Vice President, Clinical Development and Translational Science, Cardiology
Jordan Shin, MD, PhD

VICE PRESIDENT, BUSINESS & CORPORATE DEVELOPMENT
Christopher Holterhoff

Vice President, Non-clinical and Bioanalytical Development
Richie Khanna, PhD

Vice President, Corporate Controller
Ryan McHenry

Vice President, Portfolio & Program Management and Portfolio Strategy
Allen Reha

Vice President, Regulatory Affairs
Keith Wonnacott, PhD

FOUNDER & CHIEF SCIENTIFIC ADVISER
Ronald Crystal, MD